Paul Tudor Jones Prime Medicine, Inc. Transaction History
Tudor Investment Corp Et Al
- $29 Billion
- Q1 2025
A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Prime Medicine, Inc. stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 60,368 shares of PRME stock, worth $97,796. This represents 0.0% of its overall portfolio holdings.
Number of Shares
60,368Holding current value
$97,796% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding PRME
# of Institutions
130Shares Held
57.6MCall Options Held
12.4KPut Options Held
107K-
Alphabet Inc. Mountain View, CA15.1MShares$24.4 Million2.67% of portfolio
-
Black Rock Inc. New York, NY5.11MShares$8.28 Million0.0% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD4.14MShares$6.71 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.64MShares$5.9 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl3.1MShares$5.01 Million0.07% of portfolio
About Prime Medicine, Inc.
- Ticker PRME
- Shares Outstandng 95,730,200
- Market Cap $155M